ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1150

Novel Chitosan Hydrogels for the Treatment of Osteoarthritis: Mechanical Support, Lubrication and Prevention of Cartilage Degradation in a Rabbit Model of Osteoarthritis

Yves Henrotin1,2, Frédéric Oprenyeszk1, Fanny Comblain3, Jean-Emile Dubuc4, Christelle Boileau5, Mickaël Chausson6, Renaud Lecler6, Guillem Rocasalbas6, Pierre Douette6 and Sandrine Gautier6, 1Bone and Cartilage Research Unit, Arthropôle Liege, University of Liege, Liege, Belgium, 2Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Marche-en-Famenne, Belgium, 3University of Liège, Bone and Cartilage Research Unit, Arthropôle Liege, University of Liege, Liege, Belgium, 4Clinical University Saint Luc, Orthopaedic Department, Clinical University Saint Luc, Brussels, Belgium, 5Artialis S.A.,11 Avenue de l’Hôpital, Tour Giga+3, Liege, Belgium, 6Synolyne Pharma, rue Haute Claire 4, Herstal, Belgium

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Osteoarthritis, treatment and viscosupplementation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Chitosan, a glucosamine polysaccharide, is a good candidate for viscosupplementation in OA joints. Herein, we report the physico-chemical properties and the effects of an innovative chitosan hydrogels in the rabbit anterior cruciate ligament model ACLT model of OA.

Methods:

The mechanical and rheological properties of animal-free ultrapure chitosan hydrogels (Vegetech inside™, Synolyne Pharma, Belgium) were characterized using a mechanical compression equipment (Instron, US) and the Discovery Hybrid DHR-2 rheometer (TA Instruments, US). The properties were compared with those of synovial fluids and of hyaluronan: injection force, capacity to absorb shocks at walk frequency, ability to lubricate (viscosity at rest), and biodegradation kinetics. In addition, the chitosan hydrogels were mixed with patient synovial fluid (in a 1:1 ratio, v/v), and the ex vivo rheological properties of the mix were characterized.

OA was surgically induced by the transection of the anterior cruciate ligament (ACLT) in female HYLA albino rabbits. One week after surgery, animals were randomly divided into 2 groups. One group (n=9) was injected intra-articularly (right knee) with 600ml saline solution (control) and the other group (n=10) with 600ml of a chitosan hydrogel (VI002, Synolyne Pharma, Belgium). X-rays from the right knee were performed at the time of sacrifice and scored with the Kellgren and Lawrence (K&L) scale. Animals were euthanized 9 weeks after surgery and a macroscopic evaluation of cartilage was done. Histological sections of cartilage areas and of synovial membrane were evaluated according to the OARSI histopathology initiative.

Results:

Chitosan hydrogels were less prone to in vitro oxidative biodegradation than crosslinked and non crosslinked hyaluronan viscosupplements. Their mechanical and lubrication capacity are higher than those of synovial fluid and of hyaluronan viscosupplements. In addition, chitosan hydrogels were easily injected through 25G to 27G needles, with an injection force lower than that of a highly cohesive hyaluronan viscosupplement. Interestingly, when the chitosan hydrogels were mixed with the synovial fluid of OA patients, the mechanical and lubrication capacity were found to be restored.

The X-rays analysis showed a significant decrease (p=0.0079) of the K&L score in rabbits injected with the VI002 chitosan hydrogel (0.40±0.30) compared with control (1.78±0.32). The macroscopic OA cartilage lesions significantly decreased in the lateral compartment in animals treated with VI002 compared to control (21.40±2.67 with VI002 vs. 36.89±3.79 with control; p=0.0041). The synovitis histological scores, mostly synoviocytes hyperplasia and inflammatory infiltrate criteria, were significantly reduced by VI002 (13.25±0.51 with VI002 vs. 14.79±0.35 with control, p=0.0040). Finally, the injection of VI002 hydrogel significantly improved the structure of cartilage (6.54±0.35 with VI002 vs. 8.42±0.38 with control; p =0.0017).

Conclusion:

These results are confirming the high potential of the mono-dose viscosupplementation with non crosslinked chitosan hydrogels specifically designed to protect cartilage and decrease the symptoms associated with OA.


Disclosure: Y. Henrotin, Artialis, Bioiberica, Danone, Expanscience, Ibsa, Merck, Pierre Fabre, Synolyne Pharma, Tilman, 5,Founder and President of Artialis SA and Synolyne Pharma, two spin-off companies of the University of Liege, 9; F. Oprenyeszk, None; F. Comblain, None; J. E. Dubuc, None; C. Boileau, Artialis S.A., 3; M. Chausson, Synolyne Pharma, 3; R. Lecler, Synolyne Pharma, 3; G. Rocasalbas, Synolyne Pharma, 3; P. Douette, Synolyne Pharma, 3; S. Gautier, Synolyne Pharma, 3.

To cite this abstract in AMA style:

Henrotin Y, Oprenyeszk F, Comblain F, Dubuc JE, Boileau C, Chausson M, Lecler R, Rocasalbas G, Douette P, Gautier S. Novel Chitosan Hydrogels for the Treatment of Osteoarthritis: Mechanical Support, Lubrication and Prevention of Cartilage Degradation in a Rabbit Model of Osteoarthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/novel-chitosan-hydrogels-for-the-treatment-of-osteoarthritis-mechanical-support-lubrication-and-prevention-of-cartilage-degradation-in-a-rabbit-model-of-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-chitosan-hydrogels-for-the-treatment-of-osteoarthritis-mechanical-support-lubrication-and-prevention-of-cartilage-degradation-in-a-rabbit-model-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology